D-1216-2015 Class I Terminated
FDA drug recall D-1216-2015 was initiated by Hospira Inc. on Apr 23, 2015 and is designated Class I. Reason for recall: Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles. The recall status is terminated (terminated Jan 26, 2016). Affected quantity: 150,950 Vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 15, 2015
- Initiation Date
- Apr 23, 2015
- Termination Date
- Jan 26, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 150,950 Vials
Product Description
Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.
Reason for Recall
Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Distribution Pattern
U.S. Nationwide including Guam.
Code Information
Lot #: 38-515-DK, Expiry: 1 FEB 2016.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1216-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026